NYSE: CNMDConmed Corp Stock Ownership - Who owns Conmed?
Insider buying vs selling
Have Conmed Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Hollie K. Foust | CLO;Sec | 2026-11-04 | 1,124 | $53.66 | $60.31kSell |
| Brent Lalomia | Executive VP RA QA | 2026-03-06 | 26 | $39.90 | $1.04kSell |
| Brent Lalomia | Executive VP RA QA | 2025-12-31 | 31 | $40.60 | $1.26kBuy |
| Richard Glaze | Chief Information Officer | 2025-11-21 | 257 | $41.21 | $10.59kSell |
| Richard Glaze | Chief Information Officer | 2025-11-20 | 118 | $40.63 | $4.79kSell |
CNMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CNMD insiders and whales buy or sell their stock.
CNMD Shareholders
What type of owners hold Conmed Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Eugene R. Corasanti | 0.83% | 246,029 | $12.42M | Insider |
| Joseph J. Corasanti | 0.53% | 158,156 | $7.98M | Insider |
| Curt R. Hartman | 0.31% | 93,496 | $4.72M | Insider |
| Robert D. Shallish Jr. | 0.22% | 65,575 | $3.31M | Insider |
| Heather L. Cohen | 0.16% | 47,637 | $2.40M | Insider |
| John J. Stotts | 0.15% | 45,275 | $2.29M | Insider |
| Mark E. Tryniski | 0.15% | 45,222 | $2.28M | Insider |
| John L. Workman | 0.07% | 20,891 | $1.05M | Insider |
| Mark D. Snyder | 0.07% | 20,130 | $1.02M | Insider |
| David M. Bronson | 0.06% | 17,909 | $904.05k | Insider |
CNMD vs Medical Device Stocks
Conmed Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.